Search for: "MERRELL v. U.S."
Results 1 - 20
of 354
Sorted by Relevance
|
Sort by Date
6 Apr 2012, 10:00 am
In 1993, in Daubert v. [read post]
31 Oct 2016, 7:18 am
In Daubert v. [read post]
1 Jul 2014, 11:24 am
Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993) […] [read post]
28 Jan 2007, 9:33 am
Merrell Dow, 509 U.S. 579 (1993).Pertinent text of Daubert:Nothing in the text of this Rule establishes "general acceptance" as an absolute prerequisite to admissibility. [read post]
24 Jan 2014, 4:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
28 Dec 2018, 2:22 pm
Plaintiffs in Daubert v. [read post]
15 Jun 2016, 12:34 pm
Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993). [read post]
15 Jun 2016, 12:34 pm
Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993). [read post]
13 Mar 2025, 6:47 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), in its allowance of testimony from EcoFactor’s damages expert assigning a per-unit royalty rate to the three licenses in evidence in this case. [read post]
24 Mar 2009, 11:54 am
Merrell Dow Pharmaceuticals was a U.S. [read post]
12 Jul 2007, 5:11 am
The case citation is Daubert v Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993) A Daubert motion is a motion, raised before or during trial, to exclude the presentation of unqualified evidence to a jury. [read post]
4 Apr 2007, 8:16 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), and Federal Rule of Evidence 702. [read post]
26 Feb 2017, 7:10 am
U.S.) to a “Daubert” state (based on the 1993 case of Daubert v. [read post]
22 Oct 2015, 1:29 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), you must object to an expert, such as a doctor, when his testimony does not comply with Fla. [read post]
24 Feb 2014, 6:37 pm
Merrell Dow Pharm., Inc., 509 U.S. 579 (1993). [read post]
5 Apr 2017, 3:00 am
Merrell Dow Pharmaceuticals Inc., 509 U.S. 579 (1993). [read post]
25 Oct 2011, 9:05 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 595 (1993), that “[e]xpert evidence can be both powerful and quite misleading because of the difficulty in evaluating it. [read post]
24 Jan 2010, 10:30 am
In Merrell v. [read post]
23 Apr 2012, 3:30 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), and Kumho Tire Co., Ltd. v. [read post]
16 Oct 2014, 7:10 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) and Rule 702, Fed. [read post]
